Evolus公司主管出售了相当一部分股票,因为该公司的股份下降到13.25美元。 Evolus executives sold significant portions of their stock as the company’s shares fell to $13.25.

Evolus, Inc.的CMO, Tomoko Yamagishi-Dressler和CFO, Sandra Beaver于3月18日出售了该公司股票的股份,分别减少了4.53%和4.93%。 Evolus, Inc.’s CMO, Tomoko Yamagishi-Dressler, and CFO, Sandra Beaver, sold shares of the company’s stock on March 18th, representing decreases of 4.53% and 4.93% in their holdings, respectively. Interr Rui Avelar也出售股票,导致其所有权减少7.15%。 Insider Rui Avelar also sold shares, resulting in a 7.15% decrease in his ownership. 股票在星期四的交易额降到13.25美元,市场上限为8.4253亿美元。 The stock traded down to $13.25 on Thursday, with a market cap of $842.53 million. Evolus侧重于美学产品,包括肉毒杆菌毒素制剂Jeuveau。 Evolus focuses on aesthetic products, including the botulinum toxin formulation Jeuveau.